Financials in CAD. Standardized financial statements.
A compact view of how MediPharm Labs Corp. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $45.12M | $41.96M | $33.06M | $22.12M | $21.71M | $36.01M | $129.25M | $10.20M | $0 | $0 |
| Revenue Growth? | +7.5% | +26.9% | +49.5% | +1.9% | -39.7% | -72.1% | +1167.4% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $31.16M | $29.16M | $27.21M | $24.03M | $36.96M | $79.99M | $86.34M | $6.23M | $0 | $0 |
| Gross Profit? | $13.97M | $12.80M | $5.86M | -$1.91M | -$15.25M | -$43.98M | $42.91M | $3.97M | $0 | $0 |
| Gross Margin? | +31.0% | +30.5% | +17.7% | -8.7% | -70.2% | -122.1% | +33.2% | +38.9% | 0.0% | 0.0% |
| Operating Expenses? | $22.38M | $23.61M | $24.11M | $26.88M | $27.76M | $27.05M | $35.98M | $11.99M | $988,000 | $133,936 |
| Operating Income? | -$8.41M | -$10.81M | -$18.25M | -$29.53M | -$48.92M | -$72.58M | $6.94M | -$8.03M | -$948,000 | -$133,936 |
| EBITDA? | -$6.54M | -$7.52M | -$10.48M | -$27.09M | -$38.55M | -$53.40M | $9.72M | -$7.00M | -$42,000 | $0 |
| Income Before Tax | -$8.27M | -$10.69M | -$13.36M | -$29.99M | -$54.69M | -$72.10M | $6.75M | -$8.47M | -$995,000 | -$133,936 |
| Income Tax Expense | $0 | $0 | -$276,000 | -$6,000 | $113,000 | -$4.99M | $5.62M | -$55,000 | $0 | $0 |
| Net Income? | -$8.27M | -$10.69M | -$13.08M | -$29.98M | -$54.80M | -$67.11M | $1.13M | -$8.41M | -$990,000 | -$133,936 |
| EPS? | $-0.02 | $-0.03 | $-0.04 | $-0.11 | $-0.22 | $-0.48 | $0.01 | $-0.12 | $-0.20 | $-0.07 |
| Diluted EPS? | $-0.02 | $-0.03 | $-0.04 | $-0.11 | $-0.22 | $-0.48 | $0.01 | $-0.12 | $-0.20 | $-0.07 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality